NEW YORK, NY--(Marketwire - September 16, 2008) - StemSave™, Inc., a market leader in the field of stem cell recovery and cryo-preservation, announced today that effective immediately, it is moving its corporate headquarters to New York City (its lab and cryo-preservation facilities will remain in Massachusetts). Arthur E. Greco, CEO, made the announcement today from the company’s new offices in Manhattan. “Not only does this move bring our corporate offices closer to our scientific advisors, it places us in one of the global epicenters of stem cell research. In addition, it allows us to participate in New York State’s $600 million stem cell research initiative. This is an enormous opportunity for us and for the families we serve.” StemSave’s scientific advisory council includes Dr. Jeremy Mao, DDS, PhD, a Director of the Tissue Engineering and Regenerative Medicine Laboratory (TERML) and a Professor at Columbia University, and Gordana Vunjak-Novakovic, PhD, a Director of the Laboratory for Stem Cells and Tissue Engineering and Professor of Biomedical Engineering at Columbia University.
